Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Share News (TM17)

Share Price Information for Team17 (TM17)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 280.00
Bid: 275.00
Ask: 285.00
Change: -1.00 (-0.36%)
Spread: 10.00 (3.636%)
Open: 272.50
High: 277.00
Low: 277.00
Prev. Close: 278.00
TM17 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Unbound soars on potential takeover offer

Tue, 28th Mar 2023 10:40

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Unbound Group PLC, up 95% at 7.79 pence, 12-month range 3p-40.8p. The footwear retailer says it is in discussions with clothing company WoolOvers Group about a potential takeover offer at 10.5p per share, plus one contingent value right per Unbound share. "The contingent value right would give Unbound shareholders the right to receive any net proceeds if Unbound's ongoing business interruption insurance claim relating to the Covid-19 pandemic lockdowns is successful," it explains. Unbound says it would be minded to accept an offer on such terms, which represents a hefty premium to Monday's closing price of 4p, if a firm offer is made in due course.

----------

Verditek PLC, up 48% at 1.29p, 12-month range 0.5p-3p. The green technology company wins an order worth EUR167,500 from Begian firm Roof Tile Group. Expects order to be delivered in the next 12 weeks. Says the order follows an initial trial period, which the company had mentioned back in January 2020. "Roof Tile Group will incorporate the Verditek lightweight solar panel into their roof tile to form an integrated roof solution," Verditek says.

----------

AIM - LOSERS

----------

SkinBioTherapeutics PLC, down 13% at 12.84p, 12-month range 11.34p-49.4p. The skin health-focused life sciences firm says interim revenue profit jumped to GBP76,985 in the six months to December, from GBP21,949 a year before. Pretax loss widens to GBP1.4 million from GBP1.2 million, as operational costs climb. In 2023, says focus is on reaching commercial traction with Croda, launching AxisBiotix-Ps into Europe, developing an acne product, among others targets.

----------

Team17 Group PLC, down 8.8% at 405p, 12-month range 300p-600p. The video games and educational apps firm says its CEO Debbie Bestwick will leave "once a suitable successor can be found". The search has begun, and will include internal and external candidates. Meanwhile, in 2022, says revenue jumped 52% to GBP137.4 million from GBP90.5 million in 2021, but pretax profit slipped 1.4% to GBP28.7 million from GBP29.1 million. Team17 notes GBP9.2 million in one-off acquisition-related costs. Looking ahead, it says it is mindful of global macro-economic pressures, but will focus on the areas it can control.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
14 Sep 2021 12:24

New games help Team17 to record first half

(Sharecast News) - Team17 said it was confident about its outlook as the video games developer recorded record first-half profit supported by new releases.

Read more
7 Sep 2021 16:25

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
5 Aug 2021 14:04

Canaccord downgrades Team17 to 'hold' as stock approaches target price

(Sharecast News) - Analysts at Canaccord Genuity lowered their rating on video games developer Team17 from 'buy' to 'hold' on Thursday, stating the group's share price was now approaching its target.

Read more
4 Aug 2021 14:02

IN BRIEF: Team17 trades in line with expectations in first half

IN BRIEF: Team17 trades in line with expectations in first half

Read more
4 Aug 2021 10:25

Team17 trades in line during H1

(Sharecast News) - Video games developer Team17 said on Wednesday that it had traded in line with internal exceptions throughout the six months ended 30 June.

Read more
6 Jul 2021 13:14

Tuesday broker round-up

(Sharecast News) - WM Morrison Supermarkets: Credit Suisse downgrades to neutral with a target price of 254p.

Read more
2 Jul 2021 17:08

LONDON MARKET CLOSE: Muted end in Europe as traders mull mixed US jobs

LONDON MARKET CLOSE: Muted end in Europe as traders mull mixed US jobs

Read more
2 Jul 2021 12:50

Friday broker round-up

(Sharecast News) - Informa: Berenberg upgrades to buy with a target price of 640p.

Read more
2 Jul 2021 09:57

BROKER RATINGS: Jefferies says Buy Barratt Developments and Bellway

BROKER RATINGS: Jefferies says Buy Barratt Developments and Bellway

Read more
2 Jul 2021 09:15

Team17 shares up after buying kids app-maker StoryToys via parent

Team17 shares up after buying kids app-maker StoryToys via parent

Read more
2 Jul 2021 07:37

Team17 to acquire edutainment firm StoryToys

(Sharecast News) - Video games company Team17 has agreed to acquire the business and assets of StoryToys, it announced on Friday, via the acquisition of its parent company TouchPress.

Read more
3 Jun 2021 15:51

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
18 Mar 2021 16:03

CORRECT: BROKER RATINGS: Buy Smurfit Kappa and DS Smith - Berenberg

CORRECT: BROKER RATINGS: Buy Smurfit Kappa and DS Smith - Berenberg

Read more
17 Mar 2021 09:37

BROKER RATINGS: Buy Smurfit Kappa and DS Smith, hold Mondi - Berenberg

BROKER RATINGS: Buy Smurfit Kappa and DS Smith, hold Mondi - Berenberg

Read more
16 Mar 2021 15:35

TRADING UPDATES: BioPharma Credit sees third year of consistent returns

TRADING UPDATES: BioPharma Credit sees third year of consistent returns

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.